Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q70361315)
Watch
English
A reexamination of the stable category for evaluating response in patients with advanced prostate cancer
scientific article published on 01 August 1984
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
6375857
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6375857%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 October 2019
title
A reexamination of the stable category for evaluating response in patients with advanced prostate cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
6375857
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6375857%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 October 2019
main subject
prostate cancer
1 reference
based on heuristic
inferred from title
oncology
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
author name string
N. H. Slack
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
6375857
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6375857
retrieved
11 October 2023
M. F. Brady
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
6375857
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6375857
retrieved
11 October 2023
G. P. Murphy
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
6375857
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6375857
retrieved
11 October 2023
language of work or name
English
0 references
publication date
1 August 1984
1 reference
stated in
Europe PubMed Central
PubMed ID
6375857
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6375857%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 October 2019
number of pages
11
1 reference
based on heuristic
inferred from page(s)
full work available at URL
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
published in
Cancer
1 reference
stated in
Europe PubMed Central
PubMed ID
6375857
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6375857%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 October 2019
volume
54
1 reference
stated in
Europe PubMed Central
PubMed ID
6375857
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6375857%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 October 2019
issue
3
1 reference
stated in
Europe PubMed Central
PubMed ID
6375857
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6375857%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 October 2019
page(s)
564-574
1 reference
stated in
Europe PubMed Central
PubMed ID
6375857
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6375857%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 October 2019
cites work
Cancer chemotherapy reports
series ordinal
2
volume
59
page(s)
195
author name string
Scott
publication date
1975
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
Cancer chemotherapy reports
series ordinal
3
volume
52
page(s)
641
author name string
Moore
publication date
1968
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
Chemotherapy of advanced prostatic cancer. Evaluation of response parameters
series ordinal
4
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
Estrogen treatment for cancer of the prostate. Early results with 3 doses of diethylstilbestrol and placebo
series ordinal
5
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
CLINICAL CANCER OF THE PROSTATE: A STUDY OF 4,000 CASES
series ordinal
6
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
Endocrine control of prostatic carcinoma; clinical and statistical survey of 1,818 cases
series ordinal
7
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
Proceedings: Etiology, epidemiology, and pathology of prostatic cancer.
series ordinal
9
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
Proceedings: The natural history of prostatic cancer
series ordinal
10
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
The importance of the stable category for chemotherapy treated patients with advanced and relapsing prostate cancer
series ordinal
11
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
Chemotherapy Programs of the National Prostatic Cancer Project (NPCP)
series ordinal
12
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
Overview of chemotherapy programs of the NPCP
series ordinal
13
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
Comparison of Estramustine Phosphate and Vincristine Alone or in Combination for Patients with Advanced, Hormone Refractory, Previously Irradiated Carcinoma of the Prostate
series ordinal
14
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
A comparison of hydroxyurea, methyl-chloroethyl-cyclohexy-nitrosourea and cyclophosphamide in patients with advanced carcinoma of the prostate
series ordinal
15
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone
series ordinal
16
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
The addition of chemotherapy to hormonal therapy for treatment of patients with metastatic carcinoma of the prostate
series ordinal
17
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
Comparison of Estramustine Phosphate, Methotrexate and cis-Platinum: in Patients with Advanced1 Hormone Refractory Prostate Cancer
series ordinal
18
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
A comparison of estramustine phosphate versus cis-platinum alone versus estramustine phosphate plus cis-platinum in patients with advanced hormone refractory prostate cancer who had had extensive irradiation to the pelvis or lumbosacral area
series ordinal
19
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
Value of new fluorescent immunoassay for human prostatic acid phosphatase in prostate cancer
series ordinal
21
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
The use of serum isoenzymes of alkaline and acid phosphatase as possible quantitative markers of tumor load in prostate cancer
series ordinal
23
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
Response criteria for the prostate of the USA national prostatic cancer project
series ordinal
25
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
Maximum utilization of the life table method in analyzing survival
series ordinal
26
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
Federation Proceedings
series ordinal
28
volume
13
page(s)
815
author name string
Bross
publication date
1954
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples
series ordinal
29
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
A critical analysis of response criteria in patients with prostatic cancer treated with CIS-diamminedichloride platinum II
series ordinal
31
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
Systemic treatment of advanced prostatic cancer: development of a new system for defining response.
series ordinal
32
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
A phase II evaluation of adriamycin and cis-platinum in hormone resistant prostate cancer
series ordinal
33
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
Cancer Treatment Reports
series ordinal
35
volume
60
page(s)
115
author name string
Eagan
publication date
1976
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
Cancer Treatment Reports
series ordinal
36
volume
61
page(s)
325
author name string
DeWys
publication date
1977
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
The influence of site of metastasis on tumour growth and response to chemotherapy
series ordinal
37
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
The value of nuclear bone imaging in advanced prostatic cancer
series ordinal
38
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840801)54:3%3C564::AID-CNCR2820540330%3E3.0.CO;2-6
retrieved
11 October 2023
Identifiers
DOI
10.1002/1097-0142(19840801)54:3<564::AID-CNCR2820540330>3.0.CO;2-6
1 reference
stated in
Europe PubMed Central
PubMed ID
6375857
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6375857%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 October 2019
PubMed ID
6375857
1 reference
stated in
Europe PubMed Central
PubMed ID
6375857
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6375857%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 October 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit